Astrom Research International (ARI) is a CRO and specialised consultancy focusing exclusively on the Chinese market. We turn to Western companies in the Life Science sector intending to conduct clinical research or set up operations in China. 

The strength of ARI lies in the combination of vast experience within clinical trials management, an extensive local contact network and cultural insight. All parts necessary to perform clinical research in China.

We operate through a network of high quality university hospitals in all major Chinese cities and work cooperatively with key regulatory authorities on both provincial and national level.

ARI has concluded agreements with multiple major hospitals in China in specified areas of cooperation. These agreements cover areas such as International Clinical M/C Trials in Chinese hospitals, GCP Training of Investigators and site Monitors, and Organisation of Conferences and Seminars in EU, US and China.

ARI 公司是国际性的合同研究机构(CRO), 为中国境外的制药, 生物技术, 医疗器诫以及卫生保健行业, 提供在中国市场的技术开发, 信息咨询, 临床试验(I-IV期)等专业服务.

我们同时向中国境内的医药卫生, 生物技术, 医疗器诫及保健食品行业提供国际市场的信息咨询, 注册法规咨询和注册服务, 临床试验(I-IV期)以及临床监察等服务.

我们以广泛的国际药品开发的临床试验服务经验, 以灵活性, 合国情, 易操作的解决方案, 以诚信地商业道德和严谨地科学精神, 以细致而高效的工作作风, 以实实在在的业绩, 向我们的客户提交成本合理, 质量保证的高水平成果.

如需更详细信息, 欢迎您与我们联系. 请点击 Contact.